You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 4, April 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (77)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antibodies to Components of Extractable Nuclear Antigen

Clinical Characteristics of Patients

Stephen J. Farber, MD; Giles G. Bole, MD

Arch Intern Med. 1976;136(4):425-431.


Abstract

Forty-four patients with antibodies to ribonuclease-sensitive extractable nuclear antigen (ENA), ribonuclease-resistant ENA, or both, are described. Most patients with antiribonucleoprotein (anti-RNP) antibodies have overlapping features of systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS), and polymyositis, and have a low incidence of nephritis. Most patients with antibody solely to ribonuclease-insensitive ENA have SLE; these patients with SLE are typical of the general SLE population, except that they demonstrate an increased incidence of Raynaud phenomenon. Furthermore, it is shown that antibody to ENA may occur in other rheumatic and nonrheumatic diseases, and that not all patients who have a clinical overlap of SLE and PSS that is suggestive of mixed connective tissue disease have anti-RNP antibody.

(Arch Intern Med 136:425-431, 1976)



Author Affiliations

From the Rackham Arthritis Research Unit, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor. Dr Farber is now at the University of Virginia School of Medicine, Charlottesville.


Footnotes

Received for publication Nov 20, 1975; accepted Dec 15.

Reprint requests to R4633 Kresge I, University of Michigan Medical School, Ann Arbor, MI 48104 (Dr Farber).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis
Bastian et al.
Lupus 2002;11:152-160.
ABSTRACT  

Speckled (Particulate) Epidermal Nuclear IgG Deposition in Normal Skin: Correlation of Clinical Features and Laboratory Findings in 46 Patients With a Subset of Connective Tissue Disease Characterized by Antibody to Extractable Nuclear Antigen
Prystowsky and Tuffanelli
Arch Dermatol 1978;114:705-710.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.